Postpartum Depression Epidemiology

Key Highlights:

• Postpartum Depression is defined as an episode of non-psychotic depression, according to the DSM5 criteria, occurring within one year of childbirth and affects ~20% of women within the first three months of the postpartum period. It can interfere with normal maternal-infant bonding and adversely affect acute and long-term child development. 
• The signs and symptoms of Postpartum Depression include depressed mood, loss of interest, changes in sleep patterns, change in appetite, feelings of worthlessness, inability to concentrate, and suicidal ideation. Women may also experience anxiety. Patients having Postpartum Depression may also have psychotic symptoms, which include delusions and hallucinations. 
• Early diagnosis of postpartum depression are important for women and their babies. Women should see their doctor if they continue to feel sad and have difficulty doing their usual activities for more than 2 weeks or if they have thoughts about harming themselves or the baby. 
• In 2024, the total diagnosed prevalent cases of Postpartum Depression in females were ~16, 16,000 cases. These cases are expected to reach ~16, 41,000 cases by 2034, in the 7MM. 
• For women with Postpartum Depression, having a baby becomes very distressing and difficult. However, promoting a maternal-infant bond, delivering positive parenting lessons, social support from family and healthcare providers, and good maternal sleep can help prevent Postpartum Depression.

DelveInsight’s “Postpartum Depression Epidemiology Forecast – 2034” report delivers an in-depth understanding of the Postpartum Depression, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Geography Covered

• The United States
• EU4 (Germany, France, Italy, and Spain) and the United Kingdom
• Japan

Study Period: 2021-2034

Postpartum Depression Disease Understanding

Postpartum Depression Overview

Postpartum Depression is a complex mix of physical, emotional, and behavioral changes that happen in approximately 20% of women after giving birth. Postpartum depression is linked to chemical, social, and psychological changes that happen when having a baby. The term describes a range of physical and emotional changes that many new mothers experience. There are five common forms of postpartum affective illness: the blues (baby blues, maternity blues), post-partum psychosis, post-partum obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), and post-partum panic disorder, each of which differs in its prevalence, clinical presentation, and management. Untreated Postpartum Depression can have adverse long-term effects. For the mother, the episode can be the precursor of chronic recurrent depression. 

Postpartum Depression Diagnosis

According to the DSM-5, a manual used to diagnose mental disorders, Postpartum Depression is a form of major depression that begins within 4 weeks after delivery. The diagnosis of postpartum depression is based not only on the length of time between delivery and onset but on the severity of the depression. 

The diagnosis of Postpartum Depression should be strongly considered in women who score above 12 on the Edinburgh Postnatal Depression Scale, experience symptoms that cause moderate to severe social dysfunction, report any suicidal ideation, or experience symptoms for more than 10 days. Diagnosing postpartum major depression should also include asking patients about past manic episodes. A history of mania or hypomania may indicate bipolar disorder, requiring specific pharmacologic treatment. Bipolar disorder is also associated with a higher risk of mood episodes postpartum.

Further details related to diagnosis are provided in the report…

Postpartum Depression Epidemiology

The Postpartum Depression epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by Prevalence Cases of Postpartum Depression in Mothers, Diagnosed Prevalence of Postpartum Depression in Mothers, Other Postpartum Psychiatric Illness in Mothers, Severity-Specific Diagnosed Prevalence of Postpartum Depression and Treated Cases Based on Severity in the 7MM covering the United States, EU4 (Germany, France, Italy, and Spain), United Kingdom, and Japan from 2021 to 2034. 

• In 2024, the total Prevalence Cases of Postpartum Depression in Mothers in the United States was ~830,000. These cases are expected to increase by 2034.
• The total Prevalence Cases of Postpartum Depression in Mothers in EU4 and the UK were ~606,000 in 2024. The cases will increase during the forecast period (2025–2034). 
• The total Prevalence Cases of Postpartum Depression in Mothers in Japan was ~179,000 in 2024. 
• Mild Postpartum Depression had the highest impact, affecting 283,449 mothers in 2024 in the US. Our trend estimates suggest a consistent rise in these cases during the study period (2021-2034).

Postpartum Depression Report Insights

• Postpartum Depression Patient Population 
• Country-wise Epidemiology Distribution

Postpartum Depression Report Key Strengths

• Ten Years Forecast
• The 7MM Coverage 
• Postpartum Depression Epidemiology Segmentation

Postpartum Depression Report Assessment

• Epidemiology Segmentation 
• Current Diagnostic Practices

FAQs

• What are the disease risks, burdens, and unmet needs of Postpartum Depression? What will be the growth opportunities across the 7MM concerning the patient population with Postpartum Depression?
• What is the historical and forecasted Postpartum Depression patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy

• Insights on patient burden/disease incidence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand KOLs’ perspectives around the accessibility, acceptability, and compliance-related challenges of Postpartum Depression to overcome barriers in the future.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges